Evaluation of the HD-GLIO Deep Learning Algorithm for Brain Tumour Segmentation on Postoperative MRI.
Peter Jagd SørensenJonathan Frederik CarlsenVibeke Andrée LarsenFlemming Littrup AndersenClaes Nøhr LadefogedMichael Bachmann NielsenHans Skovgaard PoulsenAdam Espe HansenPublished in: Diagnostics (Basel, Switzerland) (2023)
In the context of brain tumour response assessment, deep learning-based three-dimensional (3D) tumour segmentation has shown potential to enter the routine radiological workflow. The purpose of the present study was to perform an external evaluation of a state-of-the-art deep learning 3D brain tumour segmentation algorithm (HD-GLIO) on an independent cohort of consecutive, post-operative patients. For 66 consecutive magnetic resonance imaging examinations, we compared delineations of contrast-enhancing (CE) tumour lesions and non-enhancing T2/FLAIR hyperintense abnormality (NE) lesions by the HD-GLIO algorithm and radiologists using Dice similarity coefficients (Dice). Volume agreement was assessed using concordance correlation coefficients (CCCs) and Bland-Altman plots. The algorithm performed very well regarding the segmentation of NE volumes (median Dice = 0.79) and CE tumour volumes larger than 1.0 cm 3 (median Dice = 0.86). If considering all cases with CE tumour lesions, the performance dropped significantly (median Dice = 0.40). Volume agreement was excellent with CCCs of 0.997 (CE tumour volumes) and 0.922 (NE volumes). The findings have implications for the application of the HD-GLIO algorithm in the routine radiological workflow where small contrast-enhancing tumours will constitute a considerable share of the follow-up cases. Our study underlines that independent validations on clinical datasets are key to asserting the robustness of deep learning algorithms.
Keyphrases
- deep learning
- artificial intelligence
- convolutional neural network
- machine learning
- magnetic resonance imaging
- contrast enhanced
- computed tomography
- white matter
- patients undergoing
- newly diagnosed
- resting state
- multiple sclerosis
- end stage renal disease
- clinical practice
- brain injury
- single cell
- peritoneal dialysis
- cerebral ischemia
- blood brain barrier